OTC · Medical - Devices

Allurion Technologies Inc. (ALUR) Stock

$4.72 -14.27% OTC: ALUR Healthcare

Allurion Technologies Inc. is dedicated to combating obesity by offering a comprehensive weight management ecosystem designed for individuals with excess weight.

Valuation

MetricValue
Price$4.72
Market Cap$4.72M
P/E Ratio-0.08
P/B Ratio-0.05
P/S Ratio0.37
EPS (TTM)$-57.15
52-Week High$49.95
52-Week Low$0.55
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE44.17%
ROA-238.29%
ROCE114.37%
Gross Margin52.70%
Operating Margin-211.21%
Net Margin-264.74%
Debt/Equity-0.38
Current Ratio0.30

Annual Financials (USD)

Metric20212022202320242025
Revenue$38.0M$64.0M$53.0M$32.0M$15.0M
Operating Profit$-13.0M$-32.0M$-79.0M$-50.0M$-30.0M
Net Profit$-12.0M$-38.0M$-81.0M$-26.0M$-29.0M
EPS$20.10$-566.25$-890.70$-48.00$-57.15
Op Margin-32.7%-49.9%-147.9%-156.3%-198.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$39.0M$51.0M$72.0M$33.0M$16.0M
Total Liabilities$74.0M$84.0M$142.0M$111.0M$93.0M
Cash$26.0M$8.0M$38.0M$15.0M$5.0M
Borrowings$26.0M$60.0M$42.0M$38.0M$29.0M

Latest News

Allurion Announces Strong Start to U.S. Launch with Exceptional Early Outcomes and Growth Momentum Business Wire · Jun 2, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-14.0M$-47.0M$-64.0M$-42.0M$-29.0M
Investing Cash Flow$-2.0M$-3.0M$-3.0M$-1.0M$0
Financing Cash Flow$0$-1.0M$96.0M$-1.0M$-1.0M
Net Cash Flow$14.0M$-18.0M$30.0M$-23.0M$-10.0M
Free Cash Flow$-15.0M$-49.0M$-66.0M$-43.0M$-29.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.74
FCF Yield-481.20%
Quick Ratio0.25
Interest Coverage-14.62
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACON $2.36 -0.84% -0.24 $1.26M 0.00%
AHCO $11.17 -0.45% 8.52 $1.52B 0.00%
AMIX $12.10 -37.95% -0.17 $6.57M 0.00%
BDRXBiodexa Pharmaceuticals Plc $1.71 -3.39% 0.00 $1.28M 0.00%
BVS $13.12 -0.68% 20.85 $888.85M 0.00%

About Allurion Technologies Inc.

Allurion Technologies Inc. is dedicated to combating obesity by offering a comprehensive weight management ecosystem designed for individuals with excess weight. At the core of its solution is the Allurion Program, featuring the innovative Allurion Balloon – a novel, non-surgical, swallowable intragastric device engineered to promote significant weight loss. This program is further enhanced by the Allurion Virtual Care Suite, which provides sophisticated AI-powered remote patient monitoring, a specialized behavior modification curriculum, encrypted messaging capabilities, and virtual telehealth consultations. The firm's main operational base is located in Natick, Massachusetts.

Allurion Technologies Inc. is headquartered in US.

Allurion Technologies Inc. (ALUR) stock trades at $4.72 with a market capitalization of $4.72M. The stock is valued at a price-to-earnings (P/E) ratio of -0.08, price-to-book of -0.05, price-to-sales of 0.37. Over the past 52 weeks the stock has ranged between $0.55 and $49.95, and currently trades 90.6% below its 52-week high.

On profitability, Allurion Technologies Inc. generates a return on equity (ROE) of 44.17% — well above the market average, a sign of a high-quality business, return on capital employed of 114.37%, an operating margin of -211.21%, a net profit margin of -264.74%.

Official website: www.allurion.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides